NewsBenzingaJefferies Initiates Coverage On Haemonetics with Buy Rating, Announces Price Target of $150 Jefferies Initiates Coverage On Haemonetics with Buy Rating, Announces Price Target of $150 Benzinga 2026.11.13 13:15 (GMT+0) Open on Benzinga Other news All the questions Nvidia should answer on Tuesday — but probably won’t NYSE Parent ICE to Custody Abra's Institutional Crypto Loan Collateral Dear Klarna Stock Fans, Mark Your Calendars for November 17 Dear Starbucks Stock Fans, Mark Your Calendars for November 17 Freedom Holding Corp. Reports 81% Increase in Quarterly Revenue to $910.1 Million Robert Pattinson Is the New 007. That’s Bad News for Skydance Stock and Good News for the Film Industry.
Robert Pattinson Is the New 007. That’s Bad News for Skydance Stock and Good News for the Film Industry.